Remedium Lifecare Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Remedium Lifecare Ltd is ₹ 0.39 as of 13 Apr 15:30 . The P/E Ratio of Remedium Lifecare Ltd is 36.4 as of March 2025 .The P/E Ratio of Sanofi Consumer Healthcare India Ltd is 0 as of March 2025 . The Market Cap of Remedium Lifecare Ltd is ₹ 73.38 crore as of March 2025 .The Market Cap of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of March 2025 . The Revenue of Remedium Lifecare Ltd is ₹ 264.98 crore as of Mar '25 .The Revenue of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of Mar '25 . The EBITDA of Remedium Lifecare Ltd is ₹ 0.2 crore as of Mar '25 .The EBITDA of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of Mar '25 . The Net Profit of Remedium Lifecare Ltd is ₹ -2.05 crore as of Mar '25 .The Net Profit of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of Mar '25 . The Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on December 2024 . This represents a CAGR of 0.0% over 7 yearsThe Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 years .

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Remedium Lifecare Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Remedium Lifecare Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Remedium Lifecare Ltd is 38 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,577 Cr

What are the key factors driving the stock performance of Remedium Lifecare Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Remedium Lifecare Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remedium Lifecare Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 5, 2026, the Remedium Lifecare Ltd stock price is INR ₹0.44. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4592.6.

How do dividend payouts of Remedium Lifecare Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Remedium Lifecare Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.